Cargando…

含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348278/
https://www.ncbi.nlm.nih.gov/pubmed/30369208
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.10.013
_version_ 1783556773740806144
collection PubMed
description
format Online
Article
Text
id pubmed-7348278
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73482782020-07-16 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2018-10 /pmc/articles/PMC7348278/ /pubmed/30369208 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.10.013 Text en 2018年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
title 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
title_full 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
title_fullStr 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
title_full_unstemmed 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
title_short 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
title_sort 含利妥昔单抗联合方案治疗难治/复发血栓性血小板减少性紫癜10例临床分析
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348278/
https://www.ncbi.nlm.nih.gov/pubmed/30369208
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.10.013
work_keys_str_mv AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī
AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī
AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī
AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī
AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī
AT hánlìtuǒxīdānkàngliánhéfāngànzhìliáonánzhìfùfāxuèshuānxìngxuèxiǎobǎnjiǎnshǎoxìngzǐdiàn10lìlínchuángfēnxī